XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenue:    
Premiums and policy fees $ 1,914,317 $ 2,000,085
Ceded reinsurance premiums and policy fees (462,313) (529,761)
Net investment income 3,118,736 2,953,382
Other income 66,181 68,267
Revenue before net investment gains 4,636,921 4,491,973
Net investment gains:    
Other realized investment gains, net 975,769 37,470
Change in fair value of equity securities 16,290,482 12,376,263
Net investment gains 17,266,251 12,413,733
Total revenue 21,903,172 16,905,706
Benefits, claims and settlement expenses:    
Life 3,401,007 3,644,451
Ceded reinsurance benefits and claims (616,386) (1,165,352)
Annuity 243,966 251,735
Dividends to policyholders 81,149 81,277
Commissions and amortization of deferred policy acquisition costs (29,690) (30,283)
Amortization of cost of insurance acquired 153,542 158,954
Operating expenses 2,120,334 2,081,722
Interest expense 0 11,600
Total benefits and other expenses 5,353,922 5,034,104
Income before income taxes 16,549,250 11,871,602
Income tax expense 3,750,990 2,602,806
Net income 12,798,260 9,268,796
Net income attributable to noncontrolling interests (23,573) (29,017)
Net income attributable to common shareholders $ 12,774,687 $ 9,239,779
Amounts attributable to common shareholders:    
Basic income per share (in dollars per share) $ 4.05 $ 2.92
Diluted income per share (in dollars per share) $ 4.05 $ 2.92
Basic weighted average shares outstanding (in shares) 3,156,550 3,169,375
Diluted weighted average shares outstanding (in shares) 3,156,550 3,169,375